You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 62 No. 1, January 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (4)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Alzheimer Disease
 •Alert me on articles by topic

Bone Mineral Density and the Risk of Alzheimer Disease

Zaldy Sy Tan, MD, MPH; Sudha Seshadri, MD; Alexa Beiser, PhD; Yuqing Zhang, DSc; David Felson, MD; Marian T. Hannan, DSc; Rhoda Au, PhD; Philip A. Wolf, MD; Douglas P. Kiel, MD, MPH

Arch Neurol. 2005;62:107-111.

Background  Some, but not all, studies have suggested that estrogen replacement therapy has a beneficial effect on cognition in postmenopausal women. Bone mineral density (BMD) is a potential surrogate marker for cumulative estrogen exposure and has been associated with cognitive performance and risk of cognitive deterioration.

Objective  To examine whether low BMD in elderly individuals is associated with an increased risk of developing Alzheimer disease (AD).

Design, Setting, and Participants  Community-based prospective cohort study of 987 subjects (610 women) who were cognitively intact and had baseline BMD measured at the femoral neck, the trochanter, and the radial shaft between 1988 and 1989.

Main Outcome Measures  Incidence of AD and all-cause dementia during an 8-year follow-up period.

Results  Women in the lowest quartile of femoral neck BMD had more than twice the incidence of AD (hazard ratio, 2.04; 95% confidence interval, 1.11-3.75) and all-cause dementia (hazard ratio, 2.01; 95% confidence interval, 1.16-3.49) compared with those in higher quartiles after adjusting for age, sex, apolipoprotein E {varepsilon}4, baseline homocysteine level, education, estrogen use, smoking, and stroke. A similar but statistically nonsignificant relationship was observed between BMD of the femoral trochanter and AD, while no such relationship was seen between radial BMD and AD or all-cause dementia. In men, there was a trend toward an inverse relationship between BMD and the risk of AD, but the relationship was not statistically significant at any of the 3 sites.

Conclusions  Low femoral neck BMD was associated with approximately 2 times the risk of AD and all-cause dementia in women but not men, suggesting the possibility that cumulative estrogen exposure may influence the risk of developing AD. Additional studies are needed to confirm this correlation.


Author Affiliations: Division on Aging, Harvard Medical School (Drs Tan, Hannan, and Kiel); Departments of Neurology (Drs Seshadri, Au, and Wolf) and Medicine (Drs Seshadri, Zhang, and Felson), Boston University School of Medicine; Department of Biostatistics, Boston University School of Public Health (Dr Beiser); Hebrew Rehabilitation Center for Aged Research and Training Institute (Drs Tan, Hannan, and Kiel); and Division of Gerontology, Beth Israel Deaconess Medical Center (Drs Tan, Hannan, and Kiel); Boston, Mass.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Ageing and the brain
Peters
Postgrad. Med. J. 2006;82:84-88.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.